About this data
What it is
When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
Who files it
The insider, usually through the company, within two business days of the trade.
How current
We collect new filings throughout the day on SEC business days.
Worth knowing
Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.

All of this comes from public filings.

Open-market trades per day, last 30 days

05001,000Oct 17 · Purchases: 0Oct 17 · Sales: 0Oct 17Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 21Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 25Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 29Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 2Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 6Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 10Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 14Nov 15 · Purchases: 0Nov 15 · Sales: 0
05001,000Oct 17 · Purchases: 0Oct 17 · Sales: 0Oct 17Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 21Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 25Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 29Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 2Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 6Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 10Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 14Nov 15 · Purchases: 0Nov 15 · Sales: 0

Purchases Sales

By trade date. Insiders have two business days to file, so the most recent days fill in later.

Latest open-market insider trades

Reset

Showing: ticker LGND

Latest open-market insider trades
TradedInsiderCompanyTypeSharesPriceValueFiling
Nov 10, 2026Jason Aryeh
Director
LGND
Ligand Pharmaceuticals Incorporated
Sale500$320.20$160.1K SaleForm 4 ↗
Nov 10, 2026Jason Aryeh
Director
LGND
Ligand Pharmaceuticals Incorporated
Sale500$320.10$160.1K SaleForm 4 ↗
Nov 10, 2026Jason Aryeh
Director
LGND
Ligand Pharmaceuticals Incorporated
Sale10$320.02$3,200 SaleForm 4 ↗
Nov 10, 2026Jason Aryeh
Director
LGND
Ligand Pharmaceuticals Incorporated
Sale646$320.00$206.7K SaleForm 4 ↗
Nov 10, 2026Jason Aryeh
Director
LGND
Ligand Pharmaceuticals Incorporated
Sale844$320.00$270.1K SaleForm 4 ↗
Nov 10, 2026Jason Aryeh
Director
LGND
Ligand Pharmaceuticals Incorporated
Sale500$319.99$160.0K SaleForm 4 ↗
Nov 4, 2026Jason Aryeh
Director
LGND
Ligand Pharmaceuticals Incorporated
Sale282$319.99$90.2K SaleForm 4 ↗
Nov 2, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale120$323.14$38.8K SaleForm 4 ↗
Nov 2, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale200$321.44$64.3K SaleForm 4 ↗
Nov 2, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale320$319.97$102.4K SaleForm 4 ↗
Nov 2, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale440$318.73$140.2K SaleForm 4 ↗
Nov 2, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale280$317.91$89.0K SaleForm 4 ↗
Nov 2, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale80$314.58$25.2K SaleForm 4 ↗
Nov 2, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale403$313.75$126.4K SaleForm 4 ↗
Nov 2, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale634$312.85$198.3K SaleForm 4 ↗
Nov 2, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale520$311.72$162.1K SaleForm 4 ↗
Nov 2, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale490$310.61$152.2K SaleForm 4 ↗
Nov 2, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale522$309.91$161.8K SaleForm 4 ↗
Nov 2, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale708$308.43$218.4K SaleForm 4 ↗
Nov 2, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale283$307.39$87.0K SaleForm 4 ↗
Nov 2, 2026Jason Aryeh
Director
LGND
Ligand Pharmaceuticals Incorporated
Sale700$320.43$224.3K SaleForm 4 ↗
Oct 30, 2026Jason Aryeh
Director
LGND
Ligand Pharmaceuticals Incorporated
Sale50$320.49$16.0K SaleForm 4 ↗
Oct 30, 2026Jason Aryeh
Director
LGND
Ligand Pharmaceuticals Incorporated
Sale1,209$320.42$387.4K SaleForm 4 ↗
Oct 30, 2026Jason Aryeh
Director
LGND
Ligand Pharmaceuticals Incorporated
Sale52$320.24$16.7K SaleForm 4 ↗
Oct 30, 2026Jason Aryeh
Director
LGND
Ligand Pharmaceuticals Incorporated
Sale50$318.23$15.9K SaleForm 4 ↗
Oct 30, 2026Jason Aryeh
Director
LGND
Ligand Pharmaceuticals Incorporated
Sale50$317.74$15.9K SaleForm 4 ↗
Sep 10, 2026Martine Zimmermann
Director
LGND
Ligand Pharmaceuticals Incorporated
Sale1,200$285.00$342.0K SaleForm 4 ↗
Sep 3, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale400$288.98$115.6K SaleForm 4 ↗
Sep 3, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale385$287.53$110.7K SaleForm 4 ↗
Sep 3, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale2,115$286.36$605.7K SaleForm 4 ↗
Sep 3, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale1,800$285.17$513.3K SaleForm 4 ↗
Sep 3, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale300$283.99$85.2K SaleForm 4 ↗
Aug 12, 2026Octavio Espinoza
Chief Financial Officer
LGND
Ligand Pharmaceuticals Incorporated
Sale31,641$292.07$9.2M SaleForm 4 ↗
Aug 12, 2026Jason Haas
Director
LGND
Ligand Pharmaceuticals Incorporated
Sale7,138$292.81$2.1M SaleForm 4 ↗
Aug 3, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale409$292.82$119.8K SaleForm 4 ↗
Aug 3, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale991$291.71$289.1K SaleForm 4 ↗
Aug 3, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale200$290.60$58.1K SaleForm 4 ↗
Aug 3, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale503$289.80$145.8K SaleForm 4 ↗
Aug 3, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale356$288.75$102.8K SaleForm 4 ↗
Aug 3, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale1,214$287.77$349.4K SaleForm 4 ↗
Aug 3, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale1,032$286.80$296.0K SaleForm 4 ↗
Aug 3, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale157$285.74$44.9K SaleForm 4 ↗
Aug 3, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale33$284.55$9,390 SaleForm 4 ↗
Aug 3, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale105$284.14$29.8K SaleForm 4 ↗
Jul 1, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale600$317.15$190.3K SaleForm 4 ↗
Jul 1, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale900$315.78$284.2K SaleForm 4 ↗
Jul 1, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale100$314.58$31.5K SaleForm 4 ↗
Jul 1, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale700$313.46$219.4K SaleForm 4 ↗
Jul 1, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale1,081$312.28$337.6K SaleForm 4 ↗
Jul 1, 2026Andrew Reardon
CLO & Secretary
LGND
Ligand Pharmaceuticals Incorporated
Sale1,119$311.72$348.8K SaleForm 4 ↗

The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:41 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances